The multi-institutional ACRIN 6698 trial investigates quantitative diffusion weighted imaging (DWI) for assessment of breast cancer response to treatment. A secondary aim is to perform a test/retest study to evaluate reproducibility of ADC measures. In a subset of 91 subjects, DWI was acquired twice in the same exam, before and after patient repositioning. Tumor ADC was measured separately for each acquisition. 80% of cases were found analyzable by a standardized quality-control procedure. Reproducibility of ADC was excellent, with intraclass correlation coefficient of 0.97 (95%CI 0.95, 0.98) and agreement index of 0.83 (95%CI 0.76,0.87). Results were similar for subgroups by field strength or study visit.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords